IDH inhibition in gliomas: from preclinical models to clinical trials

R Rudà, C Horbinski, M van den Bent… - Nature Reviews …, 2024 - nature.com
Gliomas are the most common malignant primary brain tumours in adults and cannot usually
be cured with standard cancer treatments. Gliomas show intratumoural and intertumoural …

Cellular barcoding to decipher clonal dynamics in disease

VG Sankaran, JS Weissman, LI Zon - Science, 2022 - science.org
Cellular barcodes are distinct DNA sequences that enable one to track specific cells across
time or space. Recent advances in our ability to detect natural or synthetic cellular barcodes …

Evolutionary histories of breast cancer and related clones

T Nishimura, N Kakiuchi, K Yoshida, T Sakurai… - Nature, 2023 - nature.com
Recent studies have documented frequent evolution of clones carrying common cancer
mutations in apparently normal tissues, which are implicated in cancer development …

Modeling epigenetic lesions that cause gliomas

GJ Rahme, NM Javed, KL Puorro, S **n, V Hovestadt… - Cell, 2023 - cell.com
Epigenetic lesions that disrupt regulatory elements represent potential cancer drivers.
However, we lack experimental models for validating their tumorigenic impact. Here, we …

Genetic mosaicism in the human brain: from lineage tracing to neuropsychiatric disorders

S Bizzotto, CA Walsh - Nature Reviews Neuroscience, 2022 - nature.com
Genetic mosaicism is the result of the accumulation of somatic mutations in the human
genome starting from the first postzygotic cell generation and continuing throughout the …

Contrasting somatic mutation patterns in aging human neurons and oligodendrocytes

J Ganz, LJ Luquette, S Bizzotto, MB Miller, Z Zhou… - Cell, 2024 - cell.com
Characterizing somatic mutations in the brain is important for disentangling the complex
mechanisms of aging, yet little is known about mutational patterns in different brain cell …

A noncoding single-nucleotide polymorphism at 8q24 drives IDH1-mutant glioma formation

C Yanchus, KL Drucker, TM Kollmeyer, R Tsai… - Science, 2022 - science.org
Establishing causal links between inherited polymorphisms and cancer risk is challenging.
Here, we focus on the single-nucleotide polymorphism rs55705857, which confers a sixfold …

Evolving cell states and oncogenic drivers during the progression of IDH-mutant gliomas

J Wu, LN Gonzalez Castro, S Battaglia, CA El Farran… - Nature Cancer, 2024 - nature.com
Isocitrate dehydrogenase (IDH) mutants define a class of gliomas that are initially slow-
growing but inevitably progress to fatal disease. To characterize their malignant cell …

[HTML][HTML] Impact of CDKN2A/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma

LE Huang - Biomedicines, 2022 - mdpi.com
Although hotspot mutations in isocitrate dehydrogenase (IDH) genes are associated with
favorable clinical outcomes in glioma, CDKN2A/B homozygous deletion has been identified …

Reversing pathological cell states: The road less travelled can extend the therapeutic horizon

BN Kholodenko, W Kolch, OS Rukhlenko - Trends in cell biology, 2023 - cell.com
Acquisition of omics data advances at a formidable pace. Yet, our ability to utilize these data
to control cell phenotypes and design interventions that reverse pathological states lags …